🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested
This research study is a Pilot clinical trial. Pilot clinical trials often ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-01-14
Trial ID
NCT01961843
Treatments Being Tested
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of abir...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01795703
Treatments Being Tested
The purpose of this study is to determine the effect of abiraterone acetate...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2009-05
Trial ID
NCT00910754
Treatments Being Tested
The purpose of this study is to demonstrate the safety and effectiveness of...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-27
Trial ID
NCT01591122
Treatments Being Tested
Phase 1b study to assess the combination of ARV-110 (bavdegalutamide) and a...
Status
Completed
Location
Clinical Trial Site
Start Date
2022-05-13
Trial ID
NCT05177042
Treatments Being Tested
This is a phase 3, randomized, open-label study of opevesostat compared to ...
Status
Recruiting
Location
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040)
Start Date
2023-12-31
Trial ID
NCT06136624
This study is to evaluate the safety, and preliminary antitumor activity of...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-08
Trial ID
NCT07104617